PAR 1.96% 25.0¢ paradigm biopharmaceuticals limited..

Ann: PAR Appoints Business Development Consultant, page-95

  1. 957 Posts.
    lightbulb Created with Sketch. 295
    If I hear the line “having spoken to Simon” one more time I might just have an aneurism.

    Simon has proven his word doesn’t mean a thing. He took 39KP, a substantial holder, for an absolute ride. As he has done many shareholders on HC.

    Sorry Bob. Certainly not just you having chats with him but, I take no confidence from them.

    Ive held for five years and am absolutely certain this company is kaput. Biopharma just don’t want a part of this. Whether that be because of the IP/ secondary party to IPPS nature of the arrangement.

    Equally, PAR has proven themselves worse than inept at a corporate level. Scotty joining signal just how dire things have gotten. He is by no means a reputable BP operator at all. Rather a fund manager whose performance was so so (thanks in part to PAR).
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.